Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | THRB | P10828 | 6/20 | 0.40 |
| ▸ | THRA | P10827 | 5/20 | 0.40 |
| ▸ | CNR2 | P34972 | 8/20 | 0.39 |
| ▸ | CNR1 | P21554 | 6/20 | 0.39 |
| ▸ | DNM1 | Q05193 | 2/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31245765 | 0.95 | CNR2 (0.41) | THRBTHRACNR2CNR1MAPT | |
| SCHEMBL31245911 | 0.94 | THRA (0.45) | THRBTHRADNM1MAPTEPHX2 | |
| SCHEMBL31245868 | 0.92 | THRA (0.47) | THRBTHRADNM1MAPTEPHX2 | |
| SCHEMBL31245975 | 0.91 | THRA (0.42) | THRBTHRADNM1MAPTEPHX2 | |
| SCHEMBL25233267 | 0.91 | THRA (0.40) | THRBTHRACNR1DNM1EPHX2 | |
| SCHEMBL24849941 | 0.90 | EPHX2 (0.44) | THRBTHRAMAPTEPHX2 | |
| SCHEMBL22767784 | 0.90 | EPHX2 (0.44) | THRBTHRAMAPTEPHX2 | |
| SCHEMBL24849949 | 0.90 | EPHX2 (0.44) | THRBTHRAMAPTEPHX2 | |
| SCHEMBL25232569 | 0.89 | THRA (0.40) | THRBTHRACNR1DNM1EPHX2 | |
| SCHEMBL25241144 | 0.88 | DNM1 (0.42) | THRBTHRACNR1DNM1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4687854-A2 | LIPIDS AND LIPID-LIKE COMPOUNDS FOR THERAPEUTIC LIPID NANOPARTICLE (LNP) DELIVERY | Flagship Labs 114, Inc. (US) | 2026-02-11 | — | — | EP | disclosed |
| WO-2024211865-A2 | LIPIDS AND LIPID-LIKE COMPOUNDS FOR THERAPEUTIC LIPID NANOPARTICLE (LNP) DELIVERY | OMEGA THERAPEUTICS, INC. (US) | 2024-10-10 | — | — | WO | disclosed |